According to La Vanguardia, the company works on a new technology that “brings together in an innovative way, different disciplines such as engineering and medicine, and combine these with the use of micro-technologies in the biomedicine area. This new technology helps medical professionals to better understand complex neuropathologies such as epilepsy, acute pain or Alzheimer”.
The article highlights the fact that Alerio Biodevices has just closed a financial deal for one million euros to create a first line of products based on this technology, plastic devices and tools that allow the measurement of electric activity generated by neurones in vitro, in a very simple way and at a low cost.
Aleria Biodevices plans to start selling these new products by 2010.
